Skip to main content
SpringerLink
Log in

Hilar cholangiocarcinoma: the Memorial Sloan-Kettering Cancer Center experience

  • Topics
  • A new era of surgical treatment of hilar cholangiocarcinoma: comparison of leading Eastern and Western centers
  • Published:
Journal of Hepato-Biliary-Pancreatic Sciences

Abstract

Background/purpose

Hilar cholangiocarcinoma (HCCA) is a rare cancer with a low resectability rate, frequent recurrence after resection and an overall poor outcome. It is widely accepted that en bloc partial hepatectomy is a necessary part of the surgical therapy, but controversy surrounds other areas, including extent of lymphadenectomy and preoperative use of biliary drainage of the future liver remnant (FLR). This study analyzes the authors’ experience with HCCA, emphasizing outcome after resection in a more recent cohort.

Methods

All patients with HCCA evaluated at Memorial Sloan-Kettering Cancer Center (MSKCC) since 1991 were included in the initial analysis. Outcome after resection was specifically assessed in patients submitted to operation between January 2001 and September 2008. Patient demographics, preoperative evaluation, resection type, margin status, lymph node status, complications, morbidity and survival were examined. Preoperative disease staging was performed in all patients according to the Blumgart classification. Separate analyses were conducted to assess the impact of preoperative biliary drainage on the FLR and the optimal lymph node harvest. Outcomes for resected patients were analyzed by Fisher’s exact test and log rank tests.

Results

Three hundred and fifty-two patients with HCCA were evaluated since 1991, of which 118 were seen between 2001 and 2008. During this latter period, 105 (89%) patients underwent exploration, and of the 60 patients that underwent resection with curative intent, 48 (80%) had R0 resections. There were 3 perioperative deaths (5%), and 22 (28%) patients had complications. Patients with an R0 resection had the highest disease-specific survival followed by those with R1 resection when compared to unresected patients. The median follow-up period was 18 months. Classification by the Blumgart preoperative staging system predicted resectability and the likelihood of R0 resection. The benefit of pre-operative biliary drainage of the FLR appeared to be limited to patients with a predicted FLR volume of <30%. In patients with node-negative tumors, survival was greater in those with more than 7 lymph nodes harvested.

Conclusions

R0 resection including hepatectomy with negative lymph nodes is feasible in the majority of patients with resectable HCCA. This strategy is associated with a prolonged disease-specific survival.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Altmeier WA, Gall EA, Zinninger MM, et al. Sclerosing carcinoma of the major intrahepatic bile ducts. Arch Surg. 1957;75:459–61.

    Google Scholar 

  2. Klatskin G. Adenocarcinoma of the hepatic duct at its bifurcation within the porta hepatic. An unusual tumor with distinctive clinical and pathological features. Am J Med. 1965;38:241–56.

    Article  CAS  PubMed  Google Scholar 

  3. Nakeeb A, Pitt HA, Sohn TA, et al. Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors. Ann Surg. 1996;224:463–73.

    Article  CAS  PubMed  Google Scholar 

  4. Launois B, Reding R, Lebeau G, et al. Surgery for hilar cholangiocarcinoma: French experience in a collective survey of 552 extrahepatic bile duct cancers. J Hepatobiliary Pancreat Surg. 2000;7:128–34.

    Article  CAS  PubMed  Google Scholar 

  5. Vauthey JN, Blumgart LH. Recent advances in the management of cholangiocarcinomas. Semin Liver Dis. 1994;14:109–14.

    Article  CAS  PubMed  Google Scholar 

  6. Endo I, Gonen M, Yopp AC, et al. Intrahepatic cholangiocarcinoma: rising frequency, improved survival, and determinants of outcome after resection. Ann Surg. 2008;248(1):84–96.

    Article  PubMed  Google Scholar 

  7. Jarnagin WR, Schoup M. Surgical management of cholangiocarcinoma. Semin Liver Dis. 2004;23:189–99.

    Article  Google Scholar 

  8. Kosuge T, Yamamoto J, Shimada K, et al. Improved surgical results for hilar cholangiocarcinoma with procedures including major hepatic resection. Ann Surg. 1999;230:663–71.

    Article  CAS  PubMed  Google Scholar 

  9. Neuhaus P, Jonas S, Bechstein WO, et al. Extended resections for hilar cholangiocarcinoma. Ann Surg. 1999;230:808–18.

    Article  CAS  PubMed  Google Scholar 

  10. Burke EC, Jarnagin WR, Hochwald SN, et al. Hilar cholangiocarcinoma: patterns of spread, the importance of hepatic resection for curative operation, and a presurgical clinical staging system. Ann Surg. 1998;228(3):385–94.

    Article  CAS  PubMed  Google Scholar 

  11. Seyama Y, Kubota K, Sano K, et al. Long-term outcome of extended hemihepatectomy for hilar bile duct cancer with no mortality and high survival rate. Ann Surg. 2003;238:73–83.

    Article  PubMed  Google Scholar 

  12. Nagino M, Takada T, Miyazaki M, et al. Preoperative biliary drainage for biliary tract and ampullary carcinomas. J Hepatobiliary Pancreat Surg. 2008;15(1):25–30.

    Article  PubMed  Google Scholar 

  13. Nagino M, Kamyia J, Nishio H, et al. Two hundred forty consecutive portal vein embolizations before extended hepatectomy for biliary cancer: surgical outcome and long-term follow-up. Ann Surg. 2006;243:364–72.

    Article  PubMed  Google Scholar 

  14. Corvera CU, Blumgart LH, Akhurst T, et al. 18F-fluorodeoxyglucose positron emission tomography influences management decisions in patients with biliary cancer. J Am Coll Surg. 2008;206(1):57–65.

    Article  PubMed  Google Scholar 

  15. Anderson CD, Rice MH, Pinson CW, et al. Fluorodeoxyglucose PET imaging in the evaluation of gallbladder carcinoma and cholangiocarcinoma. J Gastrointest Surg. 2004;8:90–7.

    Article  PubMed  Google Scholar 

  16. Weber SM, DeMatteo RP, Fong Y, et al. Staging laparoscopy in patients with extrahepatic biliary carcinoma: analysis of 100 patients. Ann Surg. 2002;235:392–9.

    Article  PubMed  Google Scholar 

  17. Connor S, Barron E, Wigmore SJ, et al. The utility of laparoscopic assessment in the preoperative staging of suspected hilar cholangiocarcinoma. J Gastrointest Surg. 2005;9:476–80.

    Article  PubMed  Google Scholar 

  18. Bismuth H, Corlette MB. Intrahepatic cholangioenteric anastomosis in carcinoma of the hilus of the liver. Surg Obs Gyn. 1975;140:170–6.

    CAS  Google Scholar 

  19. Greene FL, Page DL, Fleming ID, et al., editors. American joint committee on cancer staging. 6th ed. New York: Springer; 2002.

    Google Scholar 

  20. Jarnagin WR, Fong Y, DeMatteo RP, et al. Staging, respectability and outcome in 225 patients with hilar cholangiocarcinomas. Ann Surg. 2001;234(4):507–19.

    Article  CAS  PubMed  Google Scholar 

  21. Sano T, Shimada K, Sakamoto Y, et al. One hundred two consecutive hepatobiliary resections for perihilar cholangiocarcinoma with zero mortality. Ann Surg. 2006;244(2):240–7.

    Article  PubMed  Google Scholar 

  22. Nagino M, Kamiya J, Arai T, et al. One hundred consecutive hepatobiliary resections for biliary hilar malignancy: preoperative blood donation, blood loss, transfusion, and outcome. Surgery. 2005;137(2):148–55.

    Article  PubMed  Google Scholar 

  23. Sewnath ME, Karsten TM, Prins MH, et al. A meta-analysis on the efficacy of preoperative biliary drainage for tumors causing obstructive jaundice. Ann Surg. 2002;236:17–27.

    Article  PubMed  Google Scholar 

  24. Abdalla EK, Hicks ME, Vauthey JN. Portal vein embolization: rationale, technique and future prospects. Br J Surg. 2001;88:1463–6.

    Article  Google Scholar 

  25. Hochwald SN, Burke EC, Jarnagin WR, et al. Association of preoperative biliary stenting with increased postoperative infectious complications in proximal cholangiocarcinoma. Arch Surg. 1999;134(3):261–6.

    Article  CAS  PubMed  Google Scholar 

  26. Kennedy TJ, Yopp A, Qin Y, et al. Role of preoperative biliary drainage of liver remnant prior to extended liver resection for hilar cholangiocarcinoma. HPB (Oxford). 2009;11(5):445–51.

    Google Scholar 

  27. Ito K, Ito H, Allen PJ, et al. Adequate lymph node assessment for extrahepatic bile duct adenocarcinoma. Ann Surg (in press).

  28. Schwartz RE, Smith DD. Lymph node dissection impact on staging and survival of extrahepatic cholangiocarcinomas, based on US population data. J Gastrointest Surg. 2007;11(2):158–65.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Hepatopancreatobiliary Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY, 10065, USA

    Flavio G. Rocha, Kenichi Matsuo, Leslie H. Blumgart & William R. Jarnagin

Authors
  1. Flavio G. Rocha
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kenichi Matsuo
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Leslie H. Blumgart
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. William R. Jarnagin
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to William R. Jarnagin.

About this article

Cite this article

Rocha, F.G., Matsuo, K., Blumgart, L.H. et al. Hilar cholangiocarcinoma: the Memorial Sloan-Kettering Cancer Center experience. J Hepatobiliary Pancreat Sci 17, 490–496 (2010). https://doi.org/10.1007/s00534-009-0205-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00534-009-0205-4

Keywords

Search

Navigation